Despite its popularity, Ozempic often leads to temporary weight loss, carries serious side effects, and most users regain ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...